197 related articles for article (PubMed ID: 19469479)
1. Identification of anxiolytic/nonsedative agents among indol-3-ylglyoxylamides acting as functionally selective agonists at the gamma-aminobutyric acid-A (GABAA) alpha2 benzodiazepine receptor.
Taliani S; Cosimelli B; Da Settimo F; Marini AM; La Motta C; Simorini F; Salerno S; Novellino E; Greco G; Cosconati S; Marinelli L; Salvetti F; L'Abbate G; Trasciatti S; Montali M; Costa B; Martini C
J Med Chem; 2009 Jun; 52(12):3723-34. PubMed ID: 19469479
[TBL] [Abstract][Full Text] [Related]
2. Studies of molecular pharmacophore/receptor models for GABAA/benzodiazepine receptor subtypes: binding affinities of substituted beta-carbolines at recombinant alpha x beta 3 gamma 2 subtypes and quantitative structure-activity relationship studies via a comparative molecular field analysis.
Huang Q; Cox ED; Gan T; Ma C; Bennett DW; McKernan RM; Cook JM
Drug Des Discov; 1999 Jul; 16(1):55-76. PubMed ID: 10466057
[TBL] [Abstract][Full Text] [Related]
3. A pyridazine series of alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
Lewis RT; Blackaby WP; Blackburn T; Jennings AS; Pike A; Wilson RA; Hallett DJ; Cook SM; Ferris P; Marshall GR; Reynolds DS; Sheppard WF; Smith AJ; Sohal B; Stanley J; Tye SJ; Wafford KA; Atack JR
J Med Chem; 2006 Apr; 49(8):2600-10. PubMed ID: 16610803
[TBL] [Abstract][Full Text] [Related]
4. Studies of molecular pharmacophore/receptor models for GABAA/BzR subtypes: binding affinities of symmetrically substituted pyrazolo[4,3-c]quinolin-3-ones at recombinant alpha x beta 3 gamma 2 subtypes and quantitative structure-activity relationship studies via a comparative molecular field analysis.
He X; Huang Q; Yu S; Ma C; McKernan R; Cook JM
Drug Des Discov; 1999 Jul; 16(1):77-91. PubMed ID: 10466058
[TBL] [Abstract][Full Text] [Related]
5. Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents.
Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
Curr Top Med Chem; 2012; 12(4):286-311. PubMed ID: 22204484
[TBL] [Abstract][Full Text] [Related]
6. 3-phenyl-6-(2-pyridyl)methyloxy-1,2,4-triazolo[3,4-a]phthalazines and analogues: high-affinity gamma-aminobutyric acid-A benzodiazepine receptor ligands with alpha 2, alpha 3, and alpha 5-subtype binding selectivity over alpha 1.
Carling RW; Moore KW; Street LJ; Wild D; Isted C; Leeson PD; Thomas S; O'Connor D; McKernan RM; Quirk K; Cook SM; Atack JR; Wafford KA; Thompson SA; Dawson GR; Ferris P; Castro JL
J Med Chem; 2004 Mar; 47(7):1807-22. PubMed ID: 15027873
[TBL] [Abstract][Full Text] [Related]
7. 7-(1,1-Dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine: a functionally selective gamma-aminobutyric acid(A) (GABA(A)) alpha2/alpha3-subtype selective agonist that exhibits potent anxiolytic activity but is not sedating in animal models.
Carling RW; Madin A; Guiblin A; Russell MG; Moore KW; Mitchinson A; Sohal B; Pike A; Cook SM; Ragan IC; McKernan RM; Quirk K; Ferris P; Marshall G; Thompson SA; Wafford KA; Dawson GR; Atack JR; Harrison T; Castro JL; Street LJ
J Med Chem; 2005 Nov; 48(23):7089-92. PubMed ID: 16279764
[TBL] [Abstract][Full Text] [Related]
8. Refinement of the benzodiazepine receptor site topology by structure-activity relationships of new N-(heteroarylmethyl)indol-3-ylglyoxylamides.
Primofiore G; Da Settimo F; Marini AM; Taliani S; La Motta C; Simorini F; Novellino E; Greco G; Cosimelli B; Ehlardo M; Sala A; Besnard F; Montali M; Martini C
J Med Chem; 2006 Apr; 49(8):2489-95. PubMed ID: 16610792
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and benzodiazepine receptor affinity of pyrazolo[1,5-a]pyrimidine derivatives. 3. New 6-(3-thienyl) series as alpha 1 selective ligands.
Selleri S; Bruni F; Costagli C; Costanzo A; Guerrini G; Ciciani G; Gratteri P; Bonaccini C; Malmberg Aiello P; Besnard F; Renard S; Costa B; Martini C
J Med Chem; 2003 Jan; 46(2):310-3. PubMed ID: 12519068
[TBL] [Abstract][Full Text] [Related]
10. Piperazine imidazo[1,5-a]quinoxaline ureas as high-affinity GABAA ligands of dual functionality.
Jacobsen EJ; Stelzer LS; TenBrink RE; Belonga KL; Carter DB; Im HK; Im WB; Sethy VH; Tang AH; VonVoigtlander PF; Petke JD; Zhong WZ; Mickelson JW
J Med Chem; 1999 Apr; 42(7):1123-44. PubMed ID: 10197957
[TBL] [Abstract][Full Text] [Related]
11. New fluoro derivatives of the pyrazolo[5,1-c][1,2,4]benzotriazine 5-oxide system: evaluation of fluorine binding properties in the benzodiazepine site on γ-aminobutyrric acid type A (GABA(A)) receptor. Design, synthesis, biological, and molecular modeling investigation.
Guerrini G; Ciciani G; Bruni F; Selleri S; Guarino C; Melani F; Montali M; Daniele S; Martini C; Ghelardini C; Norcini M; Ciattini S; Costanzo A
J Med Chem; 2010 Nov; 53(21):7532-48. PubMed ID: 20939501
[TBL] [Abstract][Full Text] [Related]
12. Discovery of imidazo[1,2-b][1,2,4]triazines as GABA(A) alpha2/3 subtype selective agonists for the treatment of anxiety.
Russell MG; Carling RW; Street LJ; Hallett DJ; Goodacre S; Mezzogori E; Reader M; Cook SM; Bromidge FA; Newman R; Smith AJ; Wafford KA; Marshall GR; Reynolds DS; Dias R; Ferris P; Stanley J; Lincoln R; Tye SJ; Sheppard WF; Sohal B; Pike A; Dominguez M; Atack JR; Castro JL
J Med Chem; 2006 Feb; 49(4):1235-8. PubMed ID: 16480260
[TBL] [Abstract][Full Text] [Related]
13. Novel N-substituted indol-3-ylglyoxylamides probing the LDi and L1/L2 lipophilic regions of the benzodiazepine receptor site in search for subtype-selective ligands.
Primofiore G; Taliani S; Da Settimo F; Marini AM; La Motta C; Simorini F; Patrizi MP; Sergianni V; Novellino E; Greco G; Cosimelli B; Calderone V; Montali M; Besnard F; Martini C
J Med Chem; 2007 Apr; 50(7):1627-34. PubMed ID: 17335185
[TBL] [Abstract][Full Text] [Related]
14. Benzodiazepine receptor ligands. 8: synthesis and pharmacological evaluation of new pyrazolo[5,1-c] [1,2,4]benzotriazine 5-oxide 3- and 8-disubstituted: high affinity ligands endowed with inverse-agonist pharmacological efficacy.
Guerrini G; Costanzo A; Ciciani G; Bruni F; Selleri S; Costagli C; Besnard F; Costa B; Martini C; De Siena G; Malmberg-Aiello P
Bioorg Med Chem; 2006 Feb; 14(3):758-75. PubMed ID: 16214350
[TBL] [Abstract][Full Text] [Related]
15. Imidazo[1,2-a]pyrazin-8-ones, imidazo[1,2-d][1,2,4]triazin-8-ones and imidazo[2,1-f][1,2,4]triazin-8-ones as alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
Goodacre SC; Hallett DJ; Carling RW; Castro JL; Reynolds DS; Pike A; Wafford KA; Newman R; Atack JR; Street LJ
Bioorg Med Chem Lett; 2006 Mar; 16(6):1582-5. PubMed ID: 16384707
[TBL] [Abstract][Full Text] [Related]
16. Development of a comprehensive pharmacophore model for the benzodiazepine receptor.
Zhang W; Koehler KF; Zhang P; Cook JM
Drug Des Discov; 1995 Jan; 12(3):193-248. PubMed ID: 7662830
[TBL] [Abstract][Full Text] [Related]
17. 6,2'-Dihydroxyflavone, a subtype-selective partial inverse agonist of GABAA receptor benzodiazepine site.
Wang F; Xu Z; Yuen CT; Chow CY; Lui YL; Tsang SY; Xue H
Neuropharmacology; 2007 Sep; 53(4):574-82. PubMed ID: 17681556
[TBL] [Abstract][Full Text] [Related]
18. Anxioselective compounds acting at the GABA(A) receptor benzodiazepine binding site.
Atack JR
Curr Drug Targets CNS Neurol Disord; 2003 Aug; 2(4):213-32. PubMed ID: 12871032
[TBL] [Abstract][Full Text] [Related]
19. Anxioselective anxiolytics: can less be more?
Basile AS; Lippa AS; Skolnick P
Eur J Pharmacol; 2004 Oct; 500(1-3):441-51. PubMed ID: 15464051
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, in vivo evaluation, and molecular modeling studies of new pyrazolo[5,1-c][1,2,4]benzotriazine 5-oxide derivatives. Identification of a bifunctional hydrogen bond area related to the inverse agonism.
Guerrini G; Ciciani G; Cambi G; Bruni F; Selleri S; Guarino C; Melani F; Montali M; Martini C; Ghelardini C; Norcini M; Costanzo A
J Med Chem; 2009 Aug; 52(15):4668-82. PubMed ID: 19591485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
